Clinical features of vaccination-associated thrombocytopenic purpura in children.
10.3345/kjp.2008.51.6.610
- Author:
Wan Soo LEE
1
;
Seung Taek YU
;
Sae Ron SHIN
;
Du Young CHOI
Author Information
1. Department of Pediatrics, Wonkwang University School of Medicine, Iksan, Korea. cdy8118@wonkwang.ac.kr
- Publication Type:Original Article
- Keywords:
Vaccination;
Thrombocytopenic purpura
- MeSH:
Anemia;
Chickenpox;
Child;
Encephalitis, Japanese;
Hematologic Diseases;
Hepatitis B;
Humans;
Immunization;
Incidence;
Influenza, Human;
Measles;
Pediatrics;
Platelet Count;
Purpura;
Purpura, Thrombocytopenic;
Purpura, Thrombocytopenic, Idiopathic;
Thrombocytopenia;
Treatment Outcome;
Vaccination;
Vaccines
- From:Korean Journal of Pediatrics
2008;51(6):610-615
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Idiopathic thrombocytopenic purpura (ITP) is a relatively common hematological disease in children. It generally occurs after exposure to a common viral infection episode; however, it may occasionally follow immunization with measles, measles-mumps-rubella (MMR), hepatitis B (HBV), influenza, diphtheria-tetanus-pertussis (DTP), or chickenpox vaccines. In this study, the incidence, clinical characteristics, and treatment outcome of vaccination-associated ITP were investigated and compared with non-vaccination-associated ITP. METHODS: The admission records of 105 pediatric ITP patients between 0-14 years of age admitted to Department of Pediatrics, Wonkwang University Hospital from January 1994 to July 2007 were retrospecitively reviewed. Patients were grouped into a vaccination-associated group and a non-vaccination-associated group according to vaccination history within the previous 1 month, and various clinical features between the two groups were statistically analyzed. RESULTS: Thirteen patients (12%) had a preceding vaccination. Eight had received DTP vaccination, 2 had received hepatitis B, and 1 each had received influenza, MMR, and Japanese B encephalitis vaccination. However, none of the patients had a recurrent thrombocytopenia after subsequent vaccinations. In the vaccination-associated group, the age was significantly lower, anemia was more common, and the risk period with blood platelet count <20x10(9)/L was significantly shorter than for the in non-vaccination-associated group. Also, wet purpura was less prominent and the remission within 1month was more frequently achieved in the vaccination-associated ITP group. CONCLUSION: Vaccination-associated ITP patients showed mild symptoms with a more benign and shorter lasting course than non-vaccination-associated ITP patients. Moreover, platelet count assessment at the time of the next immunization may not be necessary.
